ABVC BioPharma, Inc.
Price Action
Technical Summary
WEAKENINGABVC BioPharma, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 52), indicating performance broadly in line with the market. Earnings contraction of 2% provides fundamental context to the price action. However, price is extended 26% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.34 | +14.56% | ABOVE |
| 50 SMA | $1.22 | +25.82% | ABOVE |
| 100 SMA | $1.31 | +17.11% | ABOVE |
| 150 SMA | $1.62 | -5.75% | BELOW |
| 200 SMA | $1.95 | -21.63% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ABVC in an uptrend right now?
ABVC has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is ABVC overbought or oversold?
ABVC's RSI (14) is 61. The stock is in neutral territory, neither overbought nor oversold.
Is ABVC outperforming the market?
ABVC has a Relative Strength (RS) Rating of 52 out of 99. ABVC is performing about average compared to the market.
Where is ABVC in its 52-week range?
ABVC is trading at $1.53, which is 28% of its 52-week high ($5.48) and 14% above its 52-week low ($0.90).
How volatile is ABVC?
ABVC has a Beta of 1.46 and 52-week volatility of 102%. It's more volatile than the S&P 500 - expect bigger swings.